Career ops
One queue. One decision at a time.
No dashboard theater. Today is only the signals that can change your pipeline. Everything below is supporting evidence.
Queue
- 1NowAnthropic partnership terms — board call ThuOpen memo →
- 2NowSeries B term sheet from Sequoia — deadline WedDraft reply →
- 3NowCustomer churn spike in SMB — 3 flaggedResearch →
- 4PrepCompetitor Bug0 dropped enterprise to $199/seatRead brief →
- 5PrepBoard deck Q2 financials — CFO updated projectionsReview →
- 6CheckPatent filing status for agent orchestration — USPTO pendingCheck →
- 7ReportWeekly hiring pipeline review — 4 senior eng in final roundOpen report →
- 8ReportCustomer feedback digest from NPS survey — 340 responsesOpen report →
Anthropic raised valuation ceiling; Sequoia counter-bid changes cap table math
Two material signals converged overnight that shift the fundraise calculus. First, Anthropic's updated enterprise pricing model 1 prices the partnership tier 40% above Q1 rates, compressing your projected margin on the joint GTM by roughly $1.2M ARR in year one. Second, Sequoia's revised term sheet 2 introduces a full-ratchet anti-dilution clause that your current cap table model does not account for.
A · Enterprise pricing resetAnthropic's enterprise tier moved up +40% vs Q1 baseline. 1 The increase is not uniform — API compute stays flat, but the Managed Agent tier (the one relevant to your partnership) moves from $0.12/1K tokens to $0.168/1K tokens. At your projected 14M tokens/day usage, that adds $940/day or roughly $343K/yr in direct cost. 3
| Metric | Q1 Rate | New Rate | Delta |
|---|---|---|---|
| Managed Agent (per 1K tok) | $0.120 | $0.168 | +40% |
| Daily cost at 14M tok/day | $1,680 | $2,352 | +$672 |
| Projected year-one margin | $4.1M | $2.9M | −$1.2M |
| Breakeven month | Month 7 | Month 11 | +4 mo |
Revision 3 replaces the broad-based weighted-average anti-dilution with a full ratchet clause. 2 Under a down-round scenario, this would reprice all Series B shares to the lower price, diluting founders significantly more than the previous mechanism.
| Scenario | Weighted Avg | Full Ratchet | Founder dilution Δ |
|---|---|---|---|
| Flat round ($80M) | No effect | No effect | — |
| 20% down ($64M) | 2.1% additional | 8.4% additional | +6.3 pp |
| 40% down ($48M) | 4.8% additional | 19.1% additional | +14.3 pp |
Monthly SMB churn hit 3.2%, up from the 1.8% baseline — third consecutive week above trend. 5 Exit surveys from all three churned accounts cite the same friction: 6
The correlation data strongly favors the pricing hypothesis over the product hypothesis. Churned accounts have median feature adoption of 62%—actually above the segment average of 54% 7—which undermines the “they left because they didn't use it” narrative.
Is SMB churn pricing-driven or product-driven?
Pricing hypothesis: 15% increase last month, timing correlation. Product hypothesis: feature adoption 40% below median in churned accounts.
Three forecasts with probability shifts
Four reports updated today
12 sources across today’s edition
Five actions generated from today’s reads
| Scenario | Weighted Avg | Full Ratchet | Δ |
|---|---|---|---|
| Flat ($80M) | No effect | No effect | — |
| 20% down ($64M) | 2.1% | 8.4% | +6.3pp |
| 40% down ($48M) | 4.8% | 19.1% | +14.3pp |
Pulling the Cooley LLP anti-dilution primer and your existing cap table model. Drafting counter-terms with narrow-based weighted-average as the minimum protection floor...
Generating · 3 tools active